Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products.
Financial Results:
Sanofi India Ltd reported Revenues for Q2FY24 of ₹715.00 Crores up from ₹692.00 Crore year on year, a rise of 3.32%.
Total Expenses for Q2FY24 of ₹516.00 Crores down from ₹520.00 Crores year on year, a fall of 0.77%.
Consolidated Net Profit of ₹152.00 Crores up 16.03% from ₹131.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹66.09, up 16.27% from ₹56.84 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.